Shareholder Issues. If Dr. ▇▇▇▇▇▇▇▇▇▇ ▇▇ the remaining sole shareholder of the Medical Group, then in the event of death of the last survivor, if legal counsel for the Medical Group determines that ownership of the Shares by the representative or successor-in-interest to the survivor is not permitted or legal under the Professional Corporation Act, then such Shares shall be sold and transferred to the Medical Group in accordance with Article III of the Bylaws of the Medical Group. In such event, the Medical Group shall, in order to have one (1) shareholder, do one of the following: (a) The Medical Group shall sell one hundred (100) newly issued shares to Thom▇▇ ▇. ▇▇▇▇▇▇▇, ▇.D., or his designee, who shall be designated the "Successor Shareholder" hereunder, and shall agree to purchase such shares; provided that such sale shall be consummated only if Dr. ▇▇▇▇▇▇▇ ▇▇ his designee is a Qualified Medical Professional on the Board of Directors of Raytel Medical Corporation; or
Appears in 1 contract
Shareholder Issues. If Dr. ▇▇▇▇▇▇▇▇▇▇ ▇▇ the remaining sole shareholder of the Medical Group, then in the event of death of the last survivor, if legal counsel for the Medical Group determines that ownership of the Shares by the representative or successor-in-interest to the survivor is not permitted or legal under the Professional Corporation Act, then such Shares shall be sold and transferred to the Medical Group in accordance with Article III of the Bylaws of the Medical Group. In such event, the Medical Group shall, in order to have one (1) shareholder, do one of the following:
(a) The Medical Group shall sell one hundred (100) newly issued shares to Thom▇▇ ▇. ▇▇▇▇▇▇▇, ▇.D., or his designee, who shall be designated the "Successor Shareholder" hereunder, and shall agree to purchase such shares; provided that such sale shall be consummated only if Dr. ▇▇▇▇▇▇▇ ▇▇ his designee is a Qualified Medical Professional on the Board of Directors of Raytel Medical Corporation; or
Appears in 1 contract